ABSTRACT
Pulmonary vein stenosis (PVS) is a rare condition, often difficult to diagnose and associated with poor prognosis at advanced stages. Lung parenchymal abnormalities are indirect evidence of PVS and can manifest as multifocal opacities, nodular lesions, unilateral effusions, and interstitial septal thickening. These can lead to erroneous diagnoses of airway disease, pneumonia, malignancies or interstitial lung disease. This review summarizes the current literature about the approach to, evaluation and management of these patients. Our case report demonstrates that PVS is an under-recognized complication of cardiovascular surgery and should be considered in all patients presenting with respiratory symptoms after a cardiac procedure.
Subject(s)
Lung Diseases, Interstitial/diagnosis , Lung/diagnostic imaging , Magnetic Resonance Imaging/methods , Phlebography/methods , Pulmonary Veins/diagnostic imaging , Stenosis, Pulmonary Vein/diagnosis , Female , Humans , Middle AgedSubject(s)
GATA2 Deficiency/complications , GATA2 Deficiency/genetics , GATA2 Transcription Factor/genetics , Pulmonary Alveolar Proteinosis/genetics , Adult , Bronchoalveolar Lavage/methods , Dystonia/diagnosis , Female , GATA2 Deficiency/diagnosis , Homozygote , Humans , Leukopenia/etiology , Mutation , Nervous System Diseases/etiology , Nervous System Diseases/physiopathology , Pulmonary Alveolar Proteinosis/complications , Pulmonary Alveolar Proteinosis/diagnosis , Pulmonary Alveolar Proteinosis/therapy , Tomography, X-Ray Computed/methodsABSTRACT
PURPOSE: The role played by radiation therapy after pleurectomy/decortication or surgical biopsy in malignant pleural mesothelioma is uncertain. We treated patients with accelerated hypofractionated radiotherapy using helical tomotherapy and intensity-modulated arc therapy in an attempt to keep lung toxicity to a minimum. The present study reports the feasibility and toxicity of this approach. MATERIAL AND METHODS: Between 2008 and 2012, 36 patients with malignant pleural mesothelioma underwent accelerated hypofractionated radiotherapy to the hemithorax after pleurectomy/decortication (19 patients) or biopsy (17 patients). The prescription dose was 25Gy in five fractions over 5 consecutive days. RESULTS: We observed three patients with G3 pneumonitis, five cases of grade 2 dyspnea and six cases of grade 2 cough. The median follow-up was 37 months (range: 3-54 months). The median overall survival for patients who underwent pleurectomy/decortication followed by radiotherapy was 21.6 months [95% confidence interval (95% CI): 15.5-24.1] compared to 19.4 months for patients not submitted to surgery. CONCLUSION: Treatment of intact lung with pleural intensity-modulated arc irradiation in malignant pleural mesothelioma patients with malignant pleural mesothelioma proved safe and feasible, with an acceptable rate of pneumonitis. Survival rates were encouraging for both biopsy-only and pleurectomy/decortication groups. We are currently conducting a phase II dose escalation trial in a similar patient setting to prospectively evaluate the impact of radiotherapy on toxicity, disease-free survival and overall survival.
Subject(s)
Lung Neoplasms/radiotherapy , Lung Neoplasms/surgery , Mesothelioma/radiotherapy , Mesothelioma/surgery , Pleura/surgery , Pleural Neoplasms/radiotherapy , Pleural Neoplasms/surgery , Radiation Dose Hypofractionation , Radiotherapy, Intensity-Modulated , Adult , Aged , Aged, 80 and over , Biopsy , Combined Modality Therapy , Female , Humans , Lung Neoplasms/pathology , Male , Mesothelioma/pathology , Mesothelioma, Malignant , Middle Aged , Pleural Neoplasms/pathology , Retrospective StudiesABSTRACT
EBUS-TBNA and EUS-FNA are minimally invasive techniques rapidly gaining ground in the non-surgical invasive diagnostic approach to thoracic diseases due to their high accuracy and low morbidity and mortality compared to surgical techniques. Moreover, in the diagnosis and staging of lung cancer the combination of the two techniques is superior to either test alone. In this review we focus on the role of EBUS-TBNA and EUS-FNA in both malignant and non-malignant thoracic diseases.
Subject(s)
Bronchoscopy , Endoscopic Ultrasound-Guided Fine Needle Aspiration , Endosonography , Lymph Nodes/pathology , Thoracic Diseases/pathology , Thoracic Neoplasms/pathology , Biomarkers, Tumor/analysis , Humans , Immunohistochemistry , Lymph Nodes/chemistry , Lymphatic Metastasis , Neoplasm Staging , Predictive Value of Tests , Reproducibility of Results , Thoracic Neoplasms/chemistry , Tomography, X-Ray ComputedABSTRACT
A 74-year-old non-smoker female presented to our attention with a history of dyspnea and cough. CT scan revealed multiple areas of patchy ground glass attenuation associated to a diffuse mosaic oligoemia. Scattered bilateral subcentimetric pulmonary nodules were also present. Patient underwent a surgical lung biopsy. Specimens showed features of diffuse neuroendocrine hyperplasia, microhoneycombing, fibroblast foci. A final diagnosis of diffuse neuroendocrine hyperplasia with obliterative bronchiolitis and UIP was rendered.
Subject(s)
Bronchiolitis Obliterans/diagnosis , Idiopathic Pulmonary Fibrosis/diagnosis , Lung/diagnostic imaging , Multiple Pulmonary Nodules/diagnosis , Neuroendocrine Cells/pathology , Aged , Bronchiolitis Obliterans/complications , Cough/etiology , Dyspnea/etiology , Female , Humans , Hyperplasia/diagnosis , Idiopathic Pulmonary Fibrosis/complications , Lung/pathology , Multiple Pulmonary Nodules/complications , Tomography, X-Ray ComputedSubject(s)
Anti-Inflammatory Agents/adverse effects , Clobetasol/adverse effects , Foot Dermatoses/chemically induced , Hand Dermatoses/chemically induced , Hypopigmentation/chemically induced , Skin Pigmentation/drug effects , Adult , Alopecia Areata/drug therapy , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Child, Preschool , Clobetasol/administration & dosage , Clobetasol/therapeutic use , Dose-Response Relationship, Drug , Female , Humans , Male , Nails, Ingrown/complications , Nails, Malformed/complications , Paronychia/drug therapy , Paronychia/etiologyABSTRACT
BACKGROUND: Skin adverse events associated with D-Penicillamine (DPA) are common and multi-faceted, although the presence of DPA or its metabolites has never been documented in the skin, because of inherent difficulties in determining its tissue levels. Thus, the association between DPA and DPA-related dermatoses has been only hypothesized on the basis of careful history, clinical observation and typical histopathological findings. OBJECTIVE: To detect DPA in biopsy specimens in a unique case of 25-year-late-onset elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum associated with a history of long-term high dose DPA, by applying a recently described analytical method to assess the presence of DPA in skin. METHODS: We used a reliable analytical method based on high-performance liquid chromatography coupled with amperometric detection to look for the presence of DPA in skin biopsy specimens. RESULTS: A chromatographic peak corresponding to DPA was evidenced in some affected skin samples collected from the patient. CONCLUSION: We documented the effective presence and the persistence after 25 years of DPA in the skin of a woman affected by elastotic cutaneous change due to a long-term therapy with DPA. This report provides further evidence of the relationship between DPA deposit in affected skin and clinical manifestation.
Subject(s)
Chelating Agents/metabolism , Hepatolenticular Degeneration/drug therapy , Penicillamine/metabolism , Skin Diseases/chemically induced , Chelating Agents/therapeutic use , Female , Humans , Middle Aged , Penicillamine/adverse effects , Penicillamine/therapeutic useABSTRACT
Granuloma annulare (GA) is a self-limited benign inflammatory dermatosis of unknown origin characterized by the development of papules arranged in an annular, circinate pattern, mainly involving the extensor surfaces of lower and upper extremities. The diagnosis depends on clinical and histological features. There are four main variants of GA: localized GA (LGA), subcutaneous GA (SGA), generalized GA (GGA) and perforating GA (PGA) and 2 uncommon subtypes: papular umbilicated GA and linear or segmental GA. Children most commonly present with the localized and subcutaneous forms. The aim of this review was to provide an update on the etiology, diagnosis and management of GA focusing on the pediatric age.
Subject(s)
Granuloma Annulare , Child , Diagnosis, Differential , Follow-Up Studies , Granuloma Annulare/classification , Granuloma Annulare/diagnosis , Granuloma Annulare/etiology , Granuloma Annulare/therapy , HumansABSTRACT
BACKGROUND: IPF is a common form of interstitial lung disease for which there is no effective therapy and usually results in death. Two previous contradictory studies showed anticoagulant therapy to be associated with both improved and worsened survival, respectively. OBJECTIVE: The objective of this retrospective cohort study was to evaluate the effect of anticoagulant therapy on the survival and disease progression of patients with idiopathic pulmonary fibrosis (IPF) in real clinical practice. METHODS: We compared the clinical characteristics, time to disease progression, incidence of acute exacerbation, and survival of 25 (20%) IPF patients receiving anticoagulant therapy to the remaining 97 IPF patients not receiving anticoagulant therapy. In addition we conducted a sensitivity analysis using as comparator a group of 25 patients matched by age, sex, functional impairment, cardiac comorbidities and pulmonary hypertension. RESULTS: Patients on anticoagulant therapy had a worse 1- and 3-year survival (84% and 53% versus 89% and 64% in the non-anticoagulant group, respectively), a difference that persisted after adjusting for age and comorbidities (hazard ratio 3.1 - 95% confidence interval, 1.4 to 7.0; p=0.006) and after comparison with the matched group (adjusted HR=4.8, 95% CI: 1.8-12.8; p=0.002). IPF patients on anticoagulant therapy had a shorter interval to disease progression ( 0.7 years versus 1.6 years, adjusted HR 2.2 -95% CI, 0.96 to 5.1; p=0.063) confirmed also in the analysis with matched subgroups (HR=2.7 (95% CI: 1.2-6.5); p=0.023). The incidence of acute exacerbations did not differ in the two groups (22% versus 23%). Two patients (8%) experienced anticoagulant treatment related complications and included an episode of hemorrhagic shock. CONCLUSION: In this retrospective study patients treated with anticoagulants had a worse survival and a shorter interval to disease progression. This support the recent finding that warfarin worsen the respiratory status and survival of IPF patients.
Subject(s)
Anticoagulants , Idiopathic Pulmonary Fibrosis , Cohort Studies , Humans , Retrospective Studies , WarfarinABSTRACT
BACKGROUND: While bronchoscopy should be considered in patients with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) in which the cause cannot be determined from history or clinical and laboratory data, there are no studies about the utility of rapid on-site examination (ROSE) of broncho-alveolar lavage for identification, as early as possible, of the pathological condition underlying the onset of this condition. The aim of this prospective, observational study was to evaluate the diagnostic role of ROSE of BAL in ALI/ARDS. METHODS: 71 patients with ALI/ARDS underwent bronchoalveolar lavage, and one part of the sample was examined with ROSE. The on-site report was categorized as diagnostic (specific diagnosis), presence of atypical reactive type II pneumocytes with no further comments or not diagnostic. RESULTS: ROSE of bronco-alveolar lavage yielded 29 (41%) specific diagnoses, revealed typical features of diffuse alveolar damage without a specific diagnosis in 28 patients (39%) and did not reveal a specific diagnosis in the remaining 14 cases (20%). CONCLUSIONS: The results of this study show that, in patients with ALI/ARDS, bronchoalveolar lavage with ROSE is diagnostic in 40% of cases: ROSE may therefore spare lung biopsies and improve the prognosis of patients with ARDS (immunocompetent or not) as therapy could be started or modified at a very early phase.
Subject(s)
Acute Lung Injury/pathology , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage/methods , Pathology, Clinical/methods , Respiratory Distress Syndrome/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Bronchoalveolar Lavage/instrumentation , Female , Humans , Male , Middle Aged , Pathology, Clinical/instrumentation , Prospective Studies , Young AdultABSTRACT
AIM: Pediatric inflammatory vulvitis (PIV) is clinically characterized by itching, soreness and inflammation and can be due to both an infective process and a non-specific irritative process, especially in atopic patients. Sometimes these non-specific PIVs, that tend to be recurrent, can be overinfected, with exacerbation of the clinical features. The importance of the cleansers, emollients, and the kind of textiles that enter in direct contact all day long with the inflamed skin, is well known. The study objective is the evaluation of the safety and efficacy of the transpiring, slightly elastic knitted silk briefs, with anti-bacterial and non-irritating properties, registered as Dermasilk®, in recurrent PIV. METHODS: The study we conducted was a prospective cohort study of 12 pre-pubertal girls, aged between 2 and 10 years, affected by recurrent PIV, that used Dermasilk® briefs in association to conventional treatments. RESULTS: Dermasilk® briefs have proven to be an effective and safe adjuvant product available for use in association with conventional drugs for the treatment of recurrent PIV. CONCLUSION: Dermasilk® briefs play an important role in the management of the flares of recurrent PIV, proven by an earlier resolution of symptoms, as well as in the maintenance of the remission and in the prevention of overinfections.
Subject(s)
Clothing , Silk , Textiles , Vulvitis/therapy , Child , Child, Preschool , Female , Humans , Pilot Projects , Prospective Studies , RecurrenceSubject(s)
Nerve Block/methods , Thoracoscopy/methods , Adolescent , Adult , Aged , Aged, 80 and over , Feasibility Studies , Humans , Middle Aged , Thoracic Vertebrae , Young AdultABSTRACT
BACKGROUND: to describe clinical, radiologic and pathologic features of lung lesions in Birt-Hogg-Dubè syndrome (BHDS) (MIM 135150). METHOD: review of 12 patients of BHDS from 3 unrelated Italian families evaluated at GB Morgagni Hospital, Forlì, from 2005 to 2010. RESULTS: mean age (±SD) at diagnosis was 44.6 (±16) years, 8 (66%) were male. All three index cases presented with a history of recurrent pneumothorax and/or cystic lung lesions evaluated by CT scan request by referring pulmonary physicians, none were diagnosed to have BHDS at the time of initial pulmonary evaluation. One of the three cases was a middle-aged female patient with a clinical phenotype indistinguishable from lymphangioleiomyomatosis (LAM), characterized by cystic lung lesions and kidney angiomyolipoma. In one case of BHDS presenting with recurrent pneumothorax and a solitary lung nodule, surgical lung resection revealed a pulmonary histiocytoma. In one case a novel mutation of BHD gene was detected (c.771 del, exon 7). CONCLUSIONS: BHDS is associated with cystic lung disease largely under-recognized by pulmonary physicians and can mimic LAM and may be associated with lung tumor, pulmonary histiocytoma. In one case we found a novel mutation in exon 7, c.771 del (ref.seq. NM_144997.5) never reported before.
Subject(s)
Birt-Hogg-Dube Syndrome/genetics , Cysts/genetics , Germ-Line Mutation/genetics , Lung Diseases/genetics , Adult , Birt-Hogg-Dube Syndrome/diagnostic imaging , Birt-Hogg-Dube Syndrome/pathology , Cysts/diagnostic imaging , Cysts/pathology , Female , Genetic Predisposition to Disease , Histiocytoma/genetics , Histiocytoma/pathology , Humans , Italy , Lung Diseases/diagnostic imaging , Lung Diseases/pathology , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Male , Middle Aged , Mutation , Pedigree , Pneumothorax/diagnostic imaging , Pneumothorax/genetics , Tomography, X-Ray Computed , Young AdultABSTRACT
Recent evidence suggests that idiopathic nonspecific interstitial pneumonia (iNSIP) is a distinct clinical entity amongst other idiopathic interstitial pneumonias, and some data seem to suggest a possible pathogenetic role of autoimmunity. The aim of the present study was to assess if iNSIP might represent an early lung manifestation of an autoimmune disease. After initial review of cases found in the medical records database by searching for the term "NSIP" (n = 63), 37 iNSIP cases were identified, and were re-evaluated using a dynamic integrated multidisciplinary approach. 27 cases with iNSIP were selected for the study. Mean ± sd age at first respiratory symptom was 54.2 ± 8 yrs, 70% were females, and 59% were never-smokers. At follow-up (mean ± sd 59.7 ± 29 months, range 12-138 months), autoimmune diseases occurred in 14 (52%) patients, with seven (26%) cases of autoimmune thyroiditis, six (22%) of undifferentiated connective tissue disease and three (11%) of connective tissue disease. Patients developing autoimmune diseases were older and more frequently never-smoking females. In >50% of patients diagnosed with iNSIP, evidence of autoimmune diseases develops within 2 yrs, suggesting a probable link between the clinical entity of iNSIP and autoimmune disorders.
Subject(s)
Autoimmune Diseases/epidemiology , Idiopathic Interstitial Pneumonias/epidemiology , Autoimmune Diseases/diagnosis , Autoimmune Diseases/diagnostic imaging , Connective Tissue Diseases/diagnosis , Connective Tissue Diseases/diagnostic imaging , Connective Tissue Diseases/epidemiology , Female , Follow-Up Studies , Humans , Idiopathic Interstitial Pneumonias/diagnosis , Idiopathic Interstitial Pneumonias/diagnostic imaging , Incidence , Male , Middle Aged , Prevalence , Pulmonary Fibrosis/diagnosis , Pulmonary Fibrosis/diagnostic imaging , Pulmonary Fibrosis/epidemiology , Radiography , Retrospective Studies , Smoking/epidemiology , Thyroiditis, Autoimmune/diagnosis , Thyroiditis, Autoimmune/diagnostic imaging , Thyroiditis, Autoimmune/epidemiologyABSTRACT
Lichen sclerosus (LS) shows a predilection for the genital area and occurs mostly in postmenopausal women and in prepubertal girls. We conducted a retrospective review of 15 young girls whit genital LS with onset before the menarcheal age and treated with topical clobetasol propionate 0.05%. The mean duration of follow-up was 4.7 years with relapses in nine patients after approximately 1 year from the first clearing. At the end of the study we observed that (i) potent topical steroids are safe and effective in childhood, (ii) an early aggressive treatment gives the best therapeutic response, (iii) one follow-up visit a year is required to monitor for relapsing.
Subject(s)
Anti-Inflammatory Agents/administration & dosage , Clobetasol/administration & dosage , Vulvar Lichen Sclerosus/drug therapy , Vulvar Lichen Sclerosus/pathology , Administration, Topical , Age Factors , Atrophy , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Retrospective Studies , Secondary Prevention , Treatment OutcomeABSTRACT
Dieulafoy's disease is a rare vascular malformation represented by an abnormally enlarged submucosal arterial vessel. This malformation is mostly found in gastrointestinal tract causing spontaneous bleeding although a few cases have been described in the bronchial tree. Recognizing Dieulafoy's malformation is crucial for the bronchoscopist in order to avoid biopsy that can lead to a massive hemoptysis, sometimes fatal. In this case report we show the clinical utility of endobronchial ultrasound (EBUS) in the evaluation of bronchial alteration suspicious for Dieulafoy's malformation.